Efficacy and safety of short-term 1–3 months versus standard 12 months dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials

Efficacy and safety of short-term 1–3 months versus standard 12 months dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials

Dual antiplatelet therapy (DAPT) is the basis of preventing stent thrombosis and ischemic events after percutaneous coronary intervention (PCI), but prolonging the duration of DAPT will increase the risk of bleeding. The optimal duration of DAPT after PCI remains controversial at present. The purpos...

Full description

Bibliographic Details
Main Authors: Wen-Jiao Zhang, Xuan Qiao, Xi-Ying Liang, Yan Li, Rong-Rong Yang, Zhi-Lu Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2021-07-01
Series:Platelets
Subjects:
coronary artery disease
dual antiplatelet therapy
duration
meta-analysis
percutaneous coronary intervention
Online Access:http://dx.doi.org/10.1080/09537104.2020.1786039

Similar Items

Similar Items